Correlation Between Evogene and Surface Oncology
Can any of the company-specific risk be diversified away by investing in both Evogene and Surface Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Surface Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Surface Oncology, you can compare the effects of market volatilities on Evogene and Surface Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Surface Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Surface Oncology.
Diversification Opportunities for Evogene and Surface Oncology
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Evogene and Surface is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Surface Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surface Oncology and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Surface Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surface Oncology has no effect on the direction of Evogene i.e., Evogene and Surface Oncology go up and down completely randomly.
Pair Corralation between Evogene and Surface Oncology
If you would invest 96.00 in Surface Oncology on August 26, 2024 and sell it today you would earn a total of 0.00 from holding Surface Oncology or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 0.4% |
| Values | Daily Returns |
Evogene vs. Surface Oncology
Performance |
| Timeline |
| Evogene |
| Surface Oncology |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Evogene and Surface Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evogene and Surface Oncology
The main advantage of trading using opposite Evogene and Surface Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Surface Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surface Oncology will offset losses from the drop in Surface Oncology's long position.| Evogene vs. Arcus Biosciences | Evogene vs. Fate Therapeutics | Evogene vs. Pluri Inc | Evogene vs. Lexaria Bioscience Corp |
| Surface Oncology vs. Syros Pharmaceuticals | Surface Oncology vs. Repare Therapeutics | Surface Oncology vs. Personalis | Surface Oncology vs. Evogene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |